bisoprolol has been researched along with Ventricular Fibrillation in 6 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with bisoprolol was helpful in maintaining an acceptable functional status and in preventing multiple shocks until transplantation became mandatory." | 1.29 | Familial dilated cardiomyopathy and spontaneous ventricular arrhythmias. ( Caes, F; de Pauw, M; Jordaens, L, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ni, Y | 1 |
| Wang, T | 1 |
| Zhuo, X | 1 |
| Song, B | 1 |
| Zhang, J | 1 |
| Wei, F | 1 |
| Bai, H | 1 |
| Wang, X | 1 |
| Yang, D | 1 |
| Gao, L | 1 |
| Ma, A | 1 |
| Hohnloser, SH | 1 |
| Dorian, P | 1 |
| Roberts, R | 1 |
| Gent, M | 1 |
| Israel, CW | 1 |
| Fain, E | 1 |
| Champagne, J | 1 |
| Connolly, SJ | 1 |
| Jordaens, L | 1 |
| de Pauw, M | 1 |
| Caes, F | 1 |
| Haverkamp, W | 1 |
| Hindricks, G | 1 |
| Gülker, H | 1 |
| Houle, MS | 1 |
| Altschuld, RA | 1 |
| Billman, GE | 1 |
| Ogawa, T | 1 |
| Hieda, N | 1 |
| Sugiyama, S | 1 |
| Ito, T | 1 |
| Satake, T | 1 |
| Ozawa, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| [NCT00257959] | Phase 4 | 400 participants | Interventional | 2001-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for bisoprolol and Ventricular Fibrillation
| Article | Year |
|---|---|
Antiarrhythmic properties of beta-blockers.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Bisoprolol; Humans; Metoprolol; Myocar | 1990 |
1 trial available for bisoprolol and Ventricular Fibrillation
4 other studies available for bisoprolol and Ventricular Fibrillation
| Article | Year |
|---|---|
Bisoprolol reversed small conductance calcium-activated potassium channel (SK) remodeling in a volume-overload rat model.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Apamin; Arteriovenous Fistula; Bisoprolol; Cells, C | 2013 |
Familial dilated cardiomyopathy and spontaneous ventricular arrhythmias.
Topics: Adolescent; Adult; Bisoprolol; Cardiomyopathy, Dilated; Defibrillators, Implantable; Electrocardiogr | 1996 |
Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; | 2001 |
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
Topics: Acetylglucosaminidase; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Coron | 1989 |